Home › Research › Lewy body dementia
A reevaluation of the duration of survival after the onset of dementia
Wolfson C, Wolfson DB, Asgharian M, M'Lan CE, Ostbye T, Rockwood K, Hogan DB, Clinical Progression of Dementia Study Group.. The New England journal of medicine, 2001-04-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Background Dementia shortens life expectancy; estimates of median survival after the onset of dementia have ranged from 5 to 9.3 years. Previous studies of people with existing dementia, however, may have underestimated the deleterious effects of dementia on survival by failing to consider persons with rapidly progressive illness who died before they could be included in a study (referred to as length bias). Methods We used data from the Canadian Study of Health and Aging to estimate survival from the onset of symptoms of dementia; the estimate was adjusted for length bias. A random sample of 10,263 subjects 65 years old or older from throughout Canada was screened for cognitive impairment. For those with dementia, we ascertained the date of onset and conducted follow-up for five years. Results We analyzed data on 821 subjects, of whom 396 had probable Alzheimer's disease, 252 had possible Alzheimer's disease, and 173 had vascular dementia. For the group as a whole, the unadjusted median survival was 6.6 years (95 percent confidence interval, 6.2 to 7.1). After adjustment for length bias, the estimated median survival was 3.3 years (95 percent confidence interval, 2.7 to 4.0). The median survival was 3.1 years for subjects with probable Alzheimer's disease, 3.5 years for subjects with possible Alzheimer's disease, and 3.3 years for subjects with vascular dementia. Conclusions Median survival after the onset of dementia is much shorter than has previously been estimated.
What this study adds
Evidence grade: Low
The record lists 10,263 participants. Using Canadian Study of Health and Aging data, the unadjusted median survival after dementia onset was 6.6 years, but after adjustment for length bias the estimated median survival was 3.3 years. This is a survival estimate for dementia, including Alzheimer's disease, and reports no treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wolfson, C., Wolfson, D. B., Asgharian, M., M'Lan, C. E., Ostbye, T., Rockwood, K., et al. (2001). A reevaluation of the duration of survival after the onset of dementia. The New England journal of medicine. https://doi.org/10.1056/nejm200104123441501
Vancouver
Wolfson C, Wolfson DB, Asgharian M, M'Lan CE, Ostbye T, Rockwood K, et al. A reevaluation of the duration of survival after the onset of dementia. The New England journal of medicine. 2001. doi:10.1056/nejm200104123441501. PMID: 11297701.
BibTeX
@article{wolfson2001-11297701,
author = {Wolfson, C. and Wolfson, D. B. and Asgharian, M. and M'Lan, C. E. and Ostbye, T. and Rockwood, K. and Hogan, D. B. and {Clinical Progression of Dementia Study Group}},
title = {{A reevaluation of the duration of survival after the onset of dementia}},
journal = {The New England journal of medicine},
year = {2001},
doi = {10.1056/nejm200104123441501},
pmid = {11297701},
url = {https://doi.org/10.1056/nejm200104123441501}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Results We analyzed data on 821 subjects, of whom 396 had probable Alzheimer's disease, 252 had possible Alzheimer's disease, and 173 had vascular dementia.
Why it matters
Using Canadian Study of Health and Aging data, the unadjusted median survival after dementia onset was 6.6 years, but after adjustment for length bias the estimated median survival was 3.3 years. This is a survival estimate for dementia, including Alzheimer's disease, and reports no treatment, cure, or prevention.
Study details
- Participants10,263
- Evidence strengthLow
How this study scored 60/100
Published in a top-tier journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 10 / 10 | Tier 1 — top-tier general journal (The New England journal of medicine) |
| Journal's citation record | 4 / 4 | New England Journal of Medicine: journal h-index 1,505 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2001 — older than 20 years, still counted |
| Sample size | 4 / 4 | 10,263 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 557 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 20.6 citations a year over 27 year(s) since 2001 |
| Impact for its field and year | 4 / 6 | Cited 18.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 21 other studies in this library |
| Still being cited | 2 / 4 | Cited 21 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author David B. Hogan: h-index 76 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | McGill University: institution h-index 1,373 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | PubMed indexes it as a multicentre study |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 11297701) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 60 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1056/nejm200104123441501
- PubMed: 11297701
- Original source →
- Free full text: New England Journal of Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
21 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Lewy body dementia from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.